Twist Bioscience snags $33 mln
San Francisco-based Twist Bioscience, a provider of DNA synthesis, has secured $33 million in funding. The investors in this round were not named.
27 March 2017•1 min read
San Francisco-based Twist Bioscience, a provider of DNA synthesis, has secured $33 million in funding. The investors in this round were not named.
